Posted on 12/8/20
Bristol-Myers Squibb Contingent Value Rights: Final Inspection Is Happening
SummaryThe contingent value right issued to Celgene shareholders after the Bristol-Myers acquisitions are dependent on approval of Liso-cell and Ide-cell.For Liso-cell to be approved the FDA . . .
Posted on 12/8/20
Agile Therapeutics: Managing A Position Ahead Of Twirla's Launch
SummaryAgile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a $4.1B addressable . . .
Posted on 12/8/20
Could Moderna Be a Millionaire-Maker Stock?
Moderna (NASDAQ:MRNA) has made some investors quite wealthy this year. Its shares have skyrocketed over 680% year to date fueled by excitement over its COVID-19 vaccine . . .
Posted on 12/8/20
Canada Doubles Its Commitment to Moderna's Coronavirus Vaccine to 40 Million Doses
In the likely case that Canadian regulators approve Moderna's (NASDAQ:MRNA) coronavirus vaccine candidate -- mRNA-1273 -- the country will receive twice as many doses as previously . . .
Posted on 12/8/20
Agile Therapeutics: Managing A Position Ahead Of Twirla's Launch
SummaryAgile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a $4.1B addressable . . .
Posted on 12/8/20
Maryland has Confirmed More than 2,000 New Coronavirus Cases for 16 Out of the Past 23 Days
Maryland has reported more than 2,000 new coronavirus cases per day for 16 of the past 23 days after not reaching that mark at all before . . .
Posted on 12/8/20
Syndax Announces Proposed Public Offering of Common Stock
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it plans to offer and sell, subject . . .
Posted on 12/8/20
Marinus Pharmaceuticals Announces Underwritten Public Offering of Common Stock
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced an underwritten . . .
Posted on 12/8/20
NanoVibronix Closes $6M Private Placement Priced At-the-Market
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today . . .
Posted on 12/8/20
TrekIT Health Rebrands To CareAlign
TrekIt Health, the health IT startup that makes a clinical workflow platform used by physicians, is rebranding to CareAlign
Posted on 12/7/20
Holy Cross Health Adds Two Female Physicians
Holy Cross Medical Group, a multi-specialty physician employed group of more than 160 physicians providing services throughout Broward and Palm Beach counties, announces the addition of . . .
Posted on 12/7/20
Luminis Health Board Officers and New Appointments
Luminis Health announces board officers and new appointments for 2020-2021. Luminis Health Board of Trustees Gary Jobson, Chair Rene LaVigne, Vice Chair Leisa Russell, Vice Chair . . .
Posted on 12/7/20
CVS Health Corporation Cash Tender Offers for Certain Outstanding Notes
CVS Health Corporation (NYSE: CVS) announced today that it has commenced cash tender offers for (i) up to $1,500,000,000 aggregate principal amount of its 4.000% Senior . . .
Posted on 12/7/20
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Athyrium Capital Management, . . .
Posted on 12/7/20
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital . . .
Posted on 12/7/20
DLH Reports Fourth Quarter and Fiscal Year 2020 Results
ATLANTA, Dec. 07, 2020 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC), a leading provider of innovative healthcare services and solutions to federal agencies, today announced . . .
Posted on 12/7/20
Repligen Corporation Proposes Public Offering of Shares of Common Stock
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of 1.5 million shares . . .
Posted on 12/7/20
Va. Expects 480,000 COVID Vaccine Doses by End of December
Virginia expects to receive 480,000 COVID-19 vaccine doses from Pfizer and Moderna by the end of December through the federal government’s Operation Warp Speed program, the . . .
Posted on 12/7/20
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
It's not surprising in the least that the stocks of several companies in the race to develop coronavirus vaccines have been sizzling hot so far this . . .
Posted on 12/7/20
Buffett Buys Merck - And You Should, Too
SummaryMerck owns one of the best drugs in the world, Keytruda.The company has a solid growth outlook going forward.An inexpensive valuation and a solid dividend yield . . .
Posted on 12/7/20
Pfizer: Coronavirus Vaccine Playing Out, Still Inexpensive And Offering A High Yield
SummaryPfizer's vaccine for COVID looks promising and should boost revenues substantially.The company is trading at an inexpensive valuation and offers an above-average dividend yield.For those seeking . . .
Posted on 12/7/20
Is Pfizer a Great Dividend Stock?
There's a lot of excitement today surrounding Pfizer (NYSE:PFE) and the COVID-19 vaccine that it's working on with BioNTech. The vaccine is more than 90% effective . . .
Posted on 12/7/20
Is Moderna's Stock Price Ridiculously Expensive Right Now?
A hot stock can heat up to the point that its sizzle fizzles. Some investors are wondering if that fate is in store for Moderna (NASDAQ:MRNA).Excitement . . .
Posted on 12/6/20
Intellia Therapeutics Closes $201M Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 12/6/20
Cogent Biosciences Closes Upsized Public Offering of Common Stock
Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its upsized underwritten public offering . . .

